Skip to content

    Announcements

    Exciting News for WebMD Members!

    We've been busy behind the scenes building new message boards for you. You'll have new and easier ways to find messages, connect with others, and share your stories.

    And, this will all be available on your smartphone or other mobile device!

    What Do You Need to Do?

    The message board you're used to will be closing in the coming weeks. While many of your boards will be making the move to our new home, your posts will not. Want to keep a discussion going? Save posts you want to continue (this includes your member profile story), so that you can re-post them in the new message boards.

    Keep an eye here and on your email inbox, we'll be back in touch soon to give you all the information you need!


    Yours in health,
    WebMD Message Boards Management

    Treatments for Hepatitis C
    avatar
    Melissa Palmer, MD posted:
    New treatments on the way for HCV
    Was this Helpful?
    9 of 18 found this helpful
    Reply
     
    avatar
    EZDZGIRL responded:
    So exactly how much longer before the new treatments are released? I know that there are no longer any clinical trials going on in all the places that I checked, so they must be finished with that part. Just wondering.
     
    avatar
    Melissa Palmer, MD replied to EZDZGIRL's response:
    We are hoping for FDA approval for both Telaprevir and Boceprevir next summer.

    Trials are open and recruiting for both naive and nonresponder HCV patients for other protease/polymerase inhibitors.


    Helpful Tips

    New treatments for hepatitis CExpert
    I'll be appearing on Sirius Radio, channel 114 (on XM, channel 119) on Monday April 14, from 9-9:30 A.M. discussing the new protease ... More
    Was this Helpful?
    5 of 9 found this helpful

    Related Drug Reviews

    • Drug Name User Reviews

    Report Problems With Your Medications to the FDA

    FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.